Establishment Labs Holdings Inc. (ESTA) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

23/25

Growth 5 Margin 5 Expansion 5 Platform 4 Financial 4

latest quarter score

Earnings Reports

23
Establishment Labs (ESTA) Q2 2026: U.S. Revenue Jumps 141% as Minimally Invasive Platform Nears 15% of Sales
August 06, 2026
24
Establishment Labs (ESTA) Q1 2026: U.S. Revenue Soars 216%, Minimally Invasive Platform Drives Margin Expansion
May 06, 2026
19
Establishment Labs (ESTA) Q4 2025: Preserve Drives 2x ASP, U.S. Share Hits 20% in Historic Launch Year
February 25, 2026
18
Establishment Labs (ESTA) Q1 2025: U.S. Motiva Reorder Rate Hits 84%, Underscoring Share Gain Trajectory
November 05, 2025
16
Establishment Labs (ESTA) Q2 2025: U.S. Motiva Sales Reach $10.3M, Fueling 27% Direct Market Surge
August 07, 2025
18
Establishment Labs (ESTA) Q1 2025: U.S. Motiva Sales Exceed $6M, Reinforcing Share Gain Trajectory
July 04, 2025

Browse all companies